Skip to main content
. 2020 Dec 17;11:625830. doi: 10.3389/fphar.2020.625830

TABLE 1.

Baseline characteristics between three groups.

4 ml group (n = 21) 2 ml group (n = 21) 1 ml group (n = 21) p-Value a
Age (SD) 58.4 (9.6) 55.2 (10.7) 60.3 (8.6) 0.231
Female (%) 95.2 81.0 81.0 0.311
Hypertension (%) 28.6 28.6 47.6 0.327
DM (%) 19.0 19.0 28.6 0.692
Symptoms duration (SD) 54.4 (72.3) 20.6 (28.2) 49.8 (60.9) 0.134
Phalen or tinel test positive (%) 42.9 52.4 38.1 0.638
Lesion side (left, %) 45.0 40.0 61.9 0.349
Primary outcome: VAS 5.4 (1.5) 5.9 (2.1) 5.4 (1.8) 0.797
Secondary outcome
 BCTQ (SD) 43.6 (10.4) 40.8 (15.5) 38.4 (14.6) 0.902
 BCTQ-S (SD) 24.9 (6.6) 24.1 (9.3) 23.7 (10.0) 0.881
 BCTQ-F (SD) 18.7 (5.5) 16.7 (5.8) 14.7 (5.2) 0.134
 QuickDASH (SD) 24.3 (6.8) 23.1 (9.9) 22.0 (8.3) 0.666
Electrodiagnosis (SD)
 Motor DL, ms 5.6 (1.6) 5.5 (1.5) 5.4 (1.6) 0.925
 SNCV Finger-wrist 30.2 (7.2) 31.5 (7.9) 32.7 (6.6) 0.432
 SNCV Palm-wrist 25.1 (4.7) 26.9 (5.8) 26.4 (7.0) 0.572
 CSA (SD), mm2 14.11 (2.60) 14.8 (3.8) 15.3 (4.4) 0.355

D5W, 5% dextrose water; SD, standard deviation; DM, diabetes mellitus; VAS, visual analog scale; BCTQ, Boston Carpal Tunnel Syndrome Questionnaire (F, function; S, symptom severity); DL, distal latency of median nerve; SNCV, sensory nerve conduction velocity (finger-wrist, finger to wrist segment; palm-wrist, palm to wrist segment); CSA, cross-sectional area of median nerve.

a

Between-group comparison: one-way ANOVA for continuous data and chi-square test for categorical data.